A new genomic platform uses AI to enable doctors to find mutations signifying persistent or recurrent cancer cells months or years before current technologies. Read print story.
By Abigail Klein Leichman | posted 9/30/2021
A new genomic platform uses AI to enable doctors to find mutations signifying persistent or recurrent cancer cells months or years before current technologies. Read print story.
By Abigail Klein Leichman | posted 9/30/2021